Manufacturer of Controlled Substances; Notice of Registration, 8792 [E7-3296]

Download as PDF 8792 Federal Register / Vol. 72, No. 38 / Tuesday, February 27, 2007 / Notices Drug Enforcement Administration Manufacturer of Controlled Substances; Notice of Registration By Notice dated October 6, 2006, and published in the Federal Register on October 18, 2006, (71 FR 61510), Boehringer Ingelheim Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as a bulk manufacturer of the basic classes of controlled substances listed in schedules I and II: Drug Schedule cprice-sewell on PROD1PC62 with NOTICES Tetrahydrocannabinols (7370) .... Amphetamine (1100) .................. Methylphenidate (1724) .............. Methadone (9250) ...................... Methadone Intermediate (9254) Dextropropoxyphene, bulk (nondosage forms) (9273). Fentanyl(9801) ............................ I II II II II II II The company plans to manufacture the listed controlled substances in bulk for sale to its customers for formulation into finished pharmaceuticals. No comments or objections have been received. DEA has considered the factors in 21 U.S.C. 823(a) and determined that the registration of Boehringer Ingelheim Chemicals Inc. to manufacture the listed basic classes of controlled substances is consistent with the public interest at this time. DEA has investigated Boehringer Ingelheim Chemicals Inc. to ensure that the company’s registration is consistent with the public interest. The investigation has included inspection and testing of the company’s physical security systems, verification of the company’s compliance with state and local laws, and a review of the company’s background and history. Therefore, pursuant to 21 U.S.C. 823, and in accordance with 21 CFR 1301.33, the above named company is granted registration as a bulk manufacturer of the basic classes of controlled substances listed. VerDate Aug<31>2005 15:22 Feb 26, 2007 Jkt 211001 DEPARTMENT OF JUSTICE Drug Enforcement Administration Importer of Controlled Substances; Notice of Registration DEPARTMENT OF JUSTICE BILLING CODE 4410–09–P Drug Enforcement Administration BILLING CODE 7020–02–P Dated: February 16, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control, Drug Enforcement Administration. [FR Doc. E7–3299 Filed 2–26–07; 8:45 am] DEPARTMENT OF JUSTICE By order of the Commission. Issued: February 21, 2007. Marilyn R. Abbott, Secretary to the Commission. [FR Doc. E7–3390 Filed 2–26–07; 8:45 am] Dated: February 16, 2007. Joseph T. Rannazzisi, Deputy Assistant Administrator, Office of Diversion Control Drug Enforcement, Administration. [FR Doc. E7–3296 Filed 2–26–07; 8:45 am] BILLING CODE 4410–09–P of 1930, as amended (19 U.S.C. 1337), and in sections 210.45(c), 210.51(a) of the Commission’s Rules of Practice and Procedure (19 CFR 210.45(c), 210.51(a)). Importer of Controlled Substances; Notice of Registration By Notice dated November 21, 2006 and published in the Federal Register on December 1, 2006, (71 FR 69591– 69592), Johnson Matthey, Inc., Pharmaceutical Materials, 2003 Nolte Drive, West Deptford, New Jersey 08066–1742, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of the basic classes of controlled substances listed in schedule II: By Notice dated November 8, 2006 and published in the Federal Register on November 17, 2006, (71 FR 66974), Kenco VPI, Division of Kenco Group Inc., 350 Corporate Place, Chattanooga, Tennessee 37419, made application by renewal to the Drug Enforcement Administration (DEA) to be registered as an importer of Nabilone (7379), a basic class of controlled substance listed in schedule II. The company plans to import the listed controlled substance for Drug Schedule distribution to its customers. Phenylacetone (8501) .................. II No comments or objections have been Raw Opium (9600) ....................... II received. DEA has considered the Concentrate of Poppy Straw factors in 21 U.S.C. 823(a) and 952(a) (9670) ........................................ II and determined that the registration of Kenco VPI to import the basic class of The company plans to import the controlled substance is consistent with listed controlled substances as raw the public interest and with United materials for use in the manufacture of States obligations under international bulk controlled substances for treaties, conventions, or protocols in distribution to its customers. effect on May 1, 1971, at this time. DEA No comments or objections have been has investigated Kenco VPI to ensure that the company’s registration is received. DEA has considered the consistent with the public interest. The factors in 21 U.S.C. 823(a) and 952(a) investigation has included inspection and determined that the registration of Johnson Matthey Inc to import the basic and testing of the company’s physical classes of controlled substances is security systems, verification of the consistent with the public interest and company’s compliance with state and with United States obligations under local laws, and a review of the international treaties, conventions, or company’s background and history. protocols in effect on May 1, 1971, at Therefore, pursuant to 21 U.S.C. 952(a) this time. DEA has investigated Johnson and 958(a), and in accordance with 21 Matthey Inc to ensure that the CFR 1301.34, the above named company company’s registration is consistent is granted registration as an importer of with the public interest. The the basic class of controlled substance investigation has included inspection listed. and testing of the company’s physical Dated: February 16, 2007. security systems, verification of the Joseph T. Rannazzisi, company’s compliance with state and Deputy Assistant Administrator, Office of local laws, and a review of the Diversion Control, Drug Enforcement company’s background and history. Administration. Therefore, pursuant to 21 U.S.C. 952(a) and § 958(a), and in accordance with 21 [FR Doc. E7–3298 Filed 2–26–07; 8:45 am] CFR 1301.34, the above named company BILLING CODE 4410–09–P is granted registration as an importer of the basic classes of controlled substances listed. PO 00000 Frm 00115 Fmt 4703 Sfmt 4703 E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

[Federal Register Volume 72, Number 38 (Tuesday, February 27, 2007)]
[Notices]
[Page 8792]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-3296]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Manufacturer of Controlled Substances; Notice of Registration

    By Notice dated October 6, 2006, and published in the Federal 
Register on October 18, 2006, (71 FR 61510), Boehringer Ingelheim 
Chemicals Inc., 2820 N. Normandy Drive, Petersburg, Virginia 23805, 
made application by renewal to the Drug Enforcement Administration 
(DEA) to be registered as a bulk manufacturer of the basic classes of 
controlled substances listed in schedules I and II:

------------------------------------------------------------------------
                    Drug                               Schedule
------------------------------------------------------------------------
Tetrahydrocannabinols (7370)...............  I
Amphetamine (1100).........................  II
Methylphenidate (1724).....................  II
Methadone (9250)...........................  II
Methadone Intermediate (9254)..............  II
Dextropropoxyphene, bulk (non-dosage forms)  II
 (9273).
Fentanyl(9801).............................  II
------------------------------------------------------------------------

    The company plans to manufacture the listed controlled substances 
in bulk for sale to its customers for formulation into finished 
pharmaceuticals.
    No comments or objections have been received. DEA has considered 
the factors in 21 U.S.C. 823(a) and determined that the registration of 
Boehringer Ingelheim Chemicals Inc. to manufacture the listed basic 
classes of controlled substances is consistent with the public interest 
at this time. DEA has investigated Boehringer Ingelheim Chemicals Inc. 
to ensure that the company's registration is consistent with the public 
interest. The investigation has included inspection and testing of the 
company's physical security systems, verification of the company's 
compliance with state and local laws, and a review of the company's 
background and history. Therefore, pursuant to 21 U.S.C. 823, and in 
accordance with 21 CFR 1301.33, the above named company is granted 
registration as a bulk manufacturer of the basic classes of controlled 
substances listed.

    Dated: February 16, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control Drug 
Enforcement, Administration.
 [FR Doc. E7-3296 Filed 2-26-07; 8:45 am]
BILLING CODE 4410-09-P